journal article·2021-10Open access

Separation of Ultra‐High‐Density Cell Suspension via Elasto‐Inertial Microfluidics

Taehong Kwon, Kyungyong Choi, Jongyoon Han

Small· Volume 17· Issue 39

Abstract

Abstract Separation of high‐density suspension particles at high throughput is crucial for many chemical, biomedical, and environmental applications. In this study, elasto‐inertial microfluidics is used to manipulate ultra‐high‐density cells to achieve stable equilibrium positions in microchannels, aided by the inherent viscoelasticity of high‐density cell suspension. It is demonstrated that ultra‐high‐density Chinese hamster ovary cell suspension (>26 packed cell volume% (PCV%), >95 million cells mL−1) can be focused at distinct lateral equilibrium positions under high‐flow‐rate conditions (up to 10 mL min−1). The effect of flow rates, channel dimensions, and cell densities on this unique focusing behavior is studied. Cell clarification is further demonstrated using this phenomenon, from 29.7 PCV% (108.1 million cells mL−1) to 8.3 PCV% (33.2 million cells mL−1) with overall 72.1% reduction efficiency and 10 mL min−1 processing rate. This work explores an extreme case of elasto‐inertial particle focusing where ultra‐high‐density culture suspension is efficiently manipulated at high throughput. This result opens up new opportunities for practical applications of high‐particle‐density suspension manipulation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Microfluidic and Bio-sensing Technologies · Microfluidic and Capillary Electrophoresis Applications · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Laboratory of Electronics Massachusetts Institute of Technology 50 Vassar Street Cambridge MA 02142 USA

Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology 50 Vassar Street Cambridge MA 02142 USA

Department of Biological Engineering Massachusetts Institute of Technology 50 Vassar Street Cambridge MA 02142 USA

Funding

National Institute for Innovation in Manufacturing Biopharmaceuticals · National Institute of Standards and Technology

References (64)

Show source-provided references
1. 10.1016/B978-1-85617-632-3.00010-010.1016/B978-1-85617-632-3.00010-0 ↗
2. 10.1016/j.memsci.2007.02.04510.1016/j.memsci.2007.02.045 ↗
3. 10.1016/j.biortech.2018.06.10210.1016/j.biortech.2018.06.102 ↗
4. 10.1016/j.biortech.2012.04.08910.1016/j.biortech.2012.04.089 ↗
5. 10.1039/b912547g10.1039/b912547g ↗
6. 10.1039/C5LC01159K10.1039/C5LC01159K ↗
7. 10.1177/095440622092286310.1177/0954406220922863 ↗
8. 10.1002/bit.2721110.1002/bit.27211 ↗
9. 10.1016/j.jcis.2017.04.01910.1016/j.jcis.2017.04.019 ↗
10. 10.1038/s41378-020-00218-x10.1038/s41378-020-00218-x ↗
11. 10.1039/C7LC01076A10.1039/C7LC01076A ↗
12. 10.1063/1.488226510.1063/1.4882265 ↗
13. 10.1038/ncomms512010.1038/ncomms5120 ↗
14. 10.1063/1.493838910.1063/1.4938389 ↗
15. 10.1021/acs.analchem.5b0051610.1021/acs.analchem.5b00516 ↗
16. 10.1039/C6LC00162A10.1039/C6LC00162A ↗
17. 10.1063/1.496329410.1063/1.4963294 ↗
18. 10.1039/C6LC00376A10.1039/C6LC00376A ↗
19. 10.1063/1.500457210.1063/1.5004572 ↗
20. 10.1021/acs.analchem.6b0505210.1021/acs.analchem.6b05052 ↗
21. 10.1021/acs.analchem.7b0309310.1021/acs.analchem.7b03093 ↗
22. 10.1063/1.509334510.1063/1.5093345 ↗
23. 10.1007/s10404-019-2205-210.1007/s10404-019-2205-2 ↗
24. 10.1007/s10404-019-2190-510.1007/s10404-019-2190-5 ↗
25. 10.1038/s41598-017-15524-010.1038/s41598-017-15524-0 ↗
26. 10.1063/1.480464910.1063/1.4804649 ↗
27. 10.1016/S0006-3495(72)86156-310.1016/S0006-3495(72)86156-3 ↗
28. 10.1021/bm401335g10.1021/bm401335g ↗
29. 10.1103/PhysRevE.77.01191110.1103/PhysRevE.77.011911 ↗
30. 10.1002/bit.26041070910.1002/bit.260410709 ↗
31. 10.1007/978-1-4419-6494-6_110.1007/978-1-4419-6494-6_1 ↗
32. 10.1063/1.512526410.1063/1.5125264 ↗
33. 10.1007/978-981-13-6229-3_510.1007/978-981-13-6229-3_5 ↗
34. S.Goh S. M.Tan D. S.Tan Y. S.Yang in20th Int. Conf. on Miniaturized Systems for Chemistry and Life Sciences Curran Associates Inc. New York2016 pp.270.
35. S.Goh M.Tan US 2019/0275521 2019.
36. 10.1002/elps.20170015010.1002/elps.201700150 ↗
37. 10.3233/BIR-1975-1260310.3233/BIR-1975-12603 ↗
38. 10.1038/srep0147510.1038/srep01475 ↗
39. 10.1016/j.chroma.2019.02.01910.1016/j.chroma.2019.02.019 ↗
40. 10.1186/s12951-016-0235-410.1186/s12951-016-0235-4 ↗
41. 10.1002/admt.20200061210.1002/admt.202000612 ↗
42. Iyengar S. N. · bioRxiv: 2020.10.19.344994 · 2020
43. 10.1007/s10404-018-2182-x10.1007/s10404-018-2182-x ↗
44. 10.1016/j.biotechadv.2018.04.01110.1016/j.biotechadv.2018.04.011 ↗
45. 10.1016/j.coche.2018.10.00610.1016/j.coche.2018.10.006 ↗
46. 10.3389/fbioe.2019.0042010.3389/fbioe.2019.00420 ↗
47. 10.1002/bit.1062910.1002/bit.10629 ↗
48. 10.1023/A:100805020256110.1023/A:1008050202561 ↗
49. 10.1038/s41598-017-06949-810.1038/s41598-017-06949-8 ↗
50. 10.1021/acs.analchem.9b0583510.1021/acs.analchem.9b05835 ↗
51. 10.1016/B978-0-08-103019-6.00006-010.1016/B978-0-08-103019-6.00006-0 ↗
52. 10.5772/intechopen.8382510.5772/intechopen.83825 ↗
53. 10.1038/srep1101810.1038/srep11018 ↗
54. 10.1039/C8LC00250A10.1039/C8LC00250A ↗
55. 10.1002/bit.2770910.1002/bit.27709 ↗
56. 10.1007/s10404-019-2232-z10.1007/s10404-019-2232-z ↗
57. 10.1021/acsnano.9b0612310.1021/acsnano.9b06123 ↗
58. 10.1021/acs.analchem.8b0574910.1021/acs.analchem.8b05749 ↗
59. 10.1021/acs.analchem.6b0456410.1021/acs.analchem.6b04564 ↗
60. 10.1021/acsnano.7b0227710.1021/acsnano.7b02277 ↗
61. 10.1016/j.jenvman.2018.04.01010.1016/j.jenvman.2018.04.010 ↗
62. 10.1016/j.rser.2014.09.03710.1016/j.rser.2014.09.037 ↗
63. 10.3390/mi203031910.3390/mi2030319 ↗
64. 10.1007/3-540-45736-4_710.1007/3-540-45736-4_7 ↗